Fox2 / RBM9 Antibody [M18D7]

Katalog-Nr. F2921

Drucken

Biologische Beschreibung

Spezifität

Fox2 / RBM9 Antibody [M18D7] erkennt endogene Spiegel des gesamten Fox2 /RBM9-Proteins.

Hintergrund Fox2 / RBM9, auch bekannt als RBFOX2 (RNA-binding fox-1 homologue 2), ist ein RNA-bindendes Protein, das für die Regulation des alternativen Spleißens entscheidend ist und gewebespezifische Genexpressionsmuster durch präzise Exon-Inklusion oder -Exklusion formt. Es enthält ein RNA-Erkennungsmotiv (RRM), das UGCAUG-Sequenzen bindet und positionsabhängige Spleißergebnisse ermöglicht: Die Bindung stromabwärts von Exons fördert die Inklusion, während die Bindung stromaufwärts das Skipping induziert. RBFOX2 orchestriert gewebespezifische Spleißprogramme im Gehirn, Herz und Skelettmuskel und gewährleistet die ordnungsgemäße Entwicklung und Funktion dieser Organe. Durch die Modulation der Spleißosom-Montage und die Rekrutierung von Hilfsfaktoren wie hnRNP H1 und TFG verfeinert RBFOX2 mRNA-Isoformen, die an Zelldifferenzierung, Migration und Anregungs-Kontraktions-Kopplung beteiligt sind. Eine Dysregulation von RBFOX2 treibt die Krankheitsprogression voran, einschließlich Krebserkrankungen (z. B. Pankreasadenokarzinom) durch Veränderung des Spleißens von metastasierungsbezogenen Genen (z. B. METTL16) und Herz-Kreislauf-Erkrankungen über aberrantes Calciumkanal-Spleißen (z. B. CACNA1C). Es erhält auch die Stoffwechselhomöostase aufrecht, beeinflusst die Cholesterinverarbeitung in der Leber und steuert die neuronale Entwicklung, wo seine Störung mit kraniofazialen Defekten korreliert. RBFOX2 autoreguliert ferner sein eigenes Spleißen, um die Expressionslevel auszugleichen, wodurch es als zentraler Knotenpunkt in RNA-bindenden Proteinnetzwerken positioniert ist.

Nutzungsinformationen

Anwendung WB, IHC, IF , FCM Verdünnung
WB IHC IF FCM
1:1000 1:500 1:100 - 1:400 1:250
Reaktivität Human, Mouse
Quelle Mouse Monoclonal Antibody MW 41 kDa
Lagerpuffer PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Lagerung
(Ab dem Datum des Erhalts)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
2. Adherent cell: Aspirate the culture medium and transfer the cells into an EP tube. Wash the cells with ice-cold PBS twice. Add an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail), sonicate to lyse the cells, and incubate on ice for 30 minutes.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice.Add an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail), sonicate to lyse the cells, and incubate on ice for 30 minutes.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1389. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system. (Exposure time of at least 60s is recommended)

Referenzen

  • https://pubmed.ncbi.nlm.nih.gov/39243148/
  • https://pubmed.ncbi.nlm.nih.gov/22184459/

Anwendungsdaten

IF

Validiert von Selleck

  • F2921-IF
    Immunofluorescent analysis of SH-SY5Y cells using F2921 (green, 1:200), Hoechst (blue) and tubulin (Red).

WB

Validiert von Selleck

  • F2921-wb
    Lane 1: NIH/3T3